1. Home
  2. INLX vs CYCC Comparison

INLX vs CYCC Comparison

Compare INLX & CYCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INLX
  • CYCC
  • Stock Information
  • Founded
  • INLX 1996
  • CYCC 1992
  • Country
  • INLX United States
  • CYCC Malaysia
  • Employees
  • INLX N/A
  • CYCC N/A
  • Industry
  • INLX EDP Services
  • CYCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • INLX Technology
  • CYCC Health Care
  • Exchange
  • INLX Nasdaq
  • CYCC Nasdaq
  • Market Cap
  • INLX 62.4M
  • CYCC 61.2M
  • IPO Year
  • INLX N/A
  • CYCC N/A
  • Fundamental
  • Price
  • INLX $12.54
  • CYCC $0.35
  • Analyst Decision
  • INLX
  • CYCC
  • Analyst Count
  • INLX 0
  • CYCC 0
  • Target Price
  • INLX N/A
  • CYCC N/A
  • AVG Volume (30 Days)
  • INLX 13.1K
  • CYCC 3.6M
  • Earning Date
  • INLX 08-12-2025
  • CYCC 08-13-2025
  • Dividend Yield
  • INLX N/A
  • CYCC 44.00%
  • EPS Growth
  • INLX N/A
  • CYCC N/A
  • EPS
  • INLX N/A
  • CYCC N/A
  • Revenue
  • INLX $17,758,634.00
  • CYCC $14,000.00
  • Revenue This Year
  • INLX $7.58
  • CYCC $137.21
  • Revenue Next Year
  • INLX N/A
  • CYCC N/A
  • P/E Ratio
  • INLX N/A
  • CYCC N/A
  • Revenue Growth
  • INLX 3.21
  • CYCC N/A
  • 52 Week Low
  • INLX $5.91
  • CYCC $0.25
  • 52 Week High
  • INLX $16.50
  • CYCC $39.84
  • Technical
  • Relative Strength Index (RSI)
  • INLX 53.15
  • CYCC 25.10
  • Support Level
  • INLX $10.40
  • CYCC $0.29
  • Resistance Level
  • INLX $11.95
  • CYCC $0.46
  • Average True Range (ATR)
  • INLX 0.72
  • CYCC 0.19
  • MACD
  • INLX 0.00
  • CYCC 0.05
  • Stochastic Oscillator
  • INLX 70.86
  • CYCC 6.33

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Conversion Segment.

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib.

Share on Social Networks: